Rankings
▼
Calendar
NTRA Q1 2021 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena
NTRA
Natera, Inc.
$29B
Q1 2021 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$152M
+62.0% YoY
Gross Profit
$86M
56.1% margin
Operating Income
-$63M
-41.4% margin
Net Income
-$64M
-41.9% margin
EPS (Diluted)
$-0.74
QoQ Revenue Growth
+35.5%
Cash Flow
Operating Cash Flow
-$75M
Free Cash Flow
-$85M
Stock-Based Comp.
$23M
Balance Sheet
Total Assets
$894M
Total Liabilities
$521M
Stockholders' Equity
$372M
Cash & Equivalents
$65M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$152M
$94M
+62.0%
Gross Profit
$86M
$49M
+74.4%
Operating Income
-$63M
-$35M
-80.7%
Net Income
-$64M
-$35M
-80.5%
Revenue Segments
Product
$118M
73%
Licensing And Other
$34M
21%
Other Licensing And Other Revenue
$10M
6%
Geographic Segments
U
$145M
95%
E M E A
$4M
3%
Other Geographic Areas
$2M
1%
Americas Excluding Us
$813,000
1%
← FY 2021
All Quarters
Q2 2021 →